Inpatient diabetes management service, 30-day readmissions and length of stayof patients with diabetes

2018 ◽  
Author(s):  
Samantha Mandel ◽  
Nestoras Mathioudakis ◽  
Sherita Hill Golden ◽  
Mihail Zilbermint
2021 ◽  
pp. 193229682199319
Author(s):  
Andrew P. Demidowich ◽  
Kristine Batty ◽  
Teresa Love ◽  
Sam Sokolinsky ◽  
Lisa Grubb ◽  
...  

Background: Community hospitals account for over 84% of all hospitals and over 94% of hospital admissions in the United States. In academic settings, implementation of an Inpatient Diabetes Management Service (IDMS) model of care has been shown to reduce rates of hyper- and hypoglycemia, hospital length of stay (LOS), and associated hospital costs. However, few studies to date have evaluated the implementation of a dedicated IDMS in a community hospital setting. Methods: This retrospective study examined the effects of changing the model of inpatient diabetes consultations from a local, private endocrine practice to a full-time endocrine hospitalist on glycemic control, LOS, and 30-day readmission rates in a 267-bed community hospital. Results: Overall diabetes patient days for the hospital were similar pre- and post-intervention (20,191 vs 20,262); however, the volume of patients seen by IDMS increased significantly after changing models. Rates of hyperglycemia decreased both among patients seen by IDMS (53.8% to 42.5%, P < .0001) and those not consulted on by IDMS (33.2% to 29.9%; P < .0001). When examined over time, rates of hypoglycemia steadily decreased in the 24 months after dedicated IDMS initiation ( P = .02); no such time effect was seen prior to IDMS ( P = .34). LOS and 30DRR were not significantly different between IDMS models. Conclusions: Implementation of an endocrine hospitalist-based IDMS at a community hospital was associated with significantly decreased hyperglycemia, while avoiding concurrent increases in hypoglycemia. Further studies are needed to investigate whether these effects are associated with improvements in clinical outcomes, patient or staff satisfaction scores, or total cost of care.


2021 ◽  
Vol 21 (2) ◽  
Author(s):  
Waqas Zia Haque ◽  
Andrew Paul Demidowich ◽  
Aniket Sidhaye ◽  
Sherita Hill Golden ◽  
Mihail Zilbermint

2020 ◽  
Vol 14 (4) ◽  
pp. 705-707 ◽  
Author(s):  
Francisco J. Pasquel ◽  
Guillermo E. Umpierrez

Diabetes is associated with poor clinical outcomes in hospitalized patients with coronavirus disease 2019 (COVID-19). During this pandemic, many hospitals have already become overwhelmed around the world and are rapidly entering crisis mode. While there are global efforts to boost personal protective equipment (PPE) production, many centers are improvising care strategies, including the implementation of technology to prevent healthcare workers’ exposures and reduce the waste of invaluable PPE. Not optimizing glycemic control due to clinical inertia driven by fear or lack of supplies may lead to poor outcomes in patients with diabetes and COVID-19. Individualized care strategies, novel therapeutic regimens, and the use of diabetes technology may reduce these barriers. However, systematic evaluation of these changes in care is necessary to evaluate both patient- and community-centered outcomes.


Sign in / Sign up

Export Citation Format

Share Document